And inhibiting NLRP3 by MCC950 could ameliorate the phenotype of ARVC including fibrosis, which also support the relationship between proinflammatory and fibroblasts (Additional file 2: Fig. S10A). Here, NLRP3 is linked to arrhythmogenic right ventricular cardiomyopathy.